The ground is shifting under AI-powered health tools, and the FDA is the one moving it. For anyone in product or reg affairs, the FDA’s…
·
·
7 min read
The regulatory field for medical devices, particularly for sophisticated AI-driven health tools, is undergoing a deep transformation. Quality assurance managers, regulatory compliance officers, and medical…
·
·
7 min read
The promise of artificial intelligence in healthcare is inextricably linked to its sustained performance in the real world. While initial premarket clearance for AI-powered Software…
·
·
8 min read
The field of digital health procurement for hospitals and health systems is undergoing a deep transformation, driven by evolving regulatory clarity from the FDA. What…
·
·
8 min read
The promise of AI in healthcare is immense, yet its clinical integration hinges on more than just algorithmic prowess. For AI-driven Software as a Medical…
·
·
7 min read
The promise of artificial intelligence in cardiovascular health is undeniable, offering unprecedented capabilities for early detection, personalized treatment, and improved patient outcomes. However, the path…
·
·
7 min read
The medical device world is changing, especially for anyone building AI health tools. The FDA’s new Quality System Regulation Amendment (QMSR) is a huge part…
·
·
6 min read
The FDA had issued a final rule to regulate Laboratory Developed Tests (LDTs) that was intended to fundamentally redefine the oversight field for diagnostic technologies.…
·
·
8 min read
The promise of adaptive machine learning (ML) in Software as a Medical Device (SaMD) is deep: algorithms that continually learn and improve postmarket, enhancing diagnostic…
·
·
9 min read
New AI-powered health tools are offering incredible new ways to diagnose and treat patients. But for the developers building them, the global market is a…
·
·
7 min read